Desq Long
Sign in

Company

Ascendis Pharma A/S

ASND · CIK 0001612042

SEC FORM 4
$330,000.00

Ascendis Pharma A/S (ASND)

Acquisition (code M) of 3,000 shares at $110 per share.

Reporting Person Bodenhoff Mads · Officer Title SVP & PAO · Transaction Code M

Traded Sep 8, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001610717-26-000409 · filed 2026-09-09 · View filing →

SEC FORM 4
$810,570.00

Ascendis Pharma A/S (ASND)

Sale of 3,000 shares at $270.19 per share.

Reporting Person Bodenhoff Mads · Officer Title SVP & PAO · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001610717-26-000409 · filed 2026-09-09 · View filing →

SEC FORM 4
$62,334.59

Ascendis Pharma A/S (ASND)

Sale of 236 shares at $264.1296 per share.

Reporting Person HOLTUG LARS · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001610717-26-000395 · filed 2026-09-03 · View filing →

SEC FORM 4
$270,435.00

Ascendis Pharma A/S (ASND)

Purchase of 1,100 shares at $245.85 per share.

Reporting Person BIENAIME JEAN JACQUES · Transaction Code P

Traded Aug 14, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001610717-26-000360 · filed 2026-08-18 · View filing →

SEC FORM 4
$222,219.00

Ascendis Pharma A/S (ASND)

Purchase of 900 shares at $246.91 per share.

Reporting Person BIENAIME JEAN JACQUES · Transaction Code P

Traded Aug 14, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001610717-26-000360 · filed 2026-08-18 · View filing →